<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201302174438N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2013-04-04</date_registration>
      <primary_sponsor>Tehran University of Medical Science</primary_sponsor>
      <public_title>The Study of the Effect of Face-to-Face Education and Educational Booklet on Heart Health Indexes of the Hospitalized Patients with Myocardial Infarction</public_title>
      <acronym></acronym>
      <scientific_title>The Study of the Effect of Face-to-Face Education and Educational Booklet on Heart Health Indexes of the Hospitalized Patients with Myocardial Infarction</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2007-03-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/4736</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Myocardial Infarction.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group: Patients were educated on symptoms, causes and side effects of myocardial infarction and change of life style such as smoking cessation, increase of physical activity, observance of food and drug regime, control of blood pressure, weight and management of anxiety. Education was performed in the form of individual education by researcher in patient’s room for 20 minutes and group education (2-5 patients) in hospital’s clinic for 20 minutes by the method of face-to-face education and educational-aid tools such as educational booklet given to patients. Also a fixed telephone number and a mobile phone number were provided to answer their questions.  Follow-up was made continuously for a period of four month following the first visit by phone. Intervention 2: The control group: the control group did not receive any intervention and just Will receive only routine care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Ghani Dehkordi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bushehr University of Medical Science</address>
        <city>Bushehr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 913 282 5389</telephone>
        <email>fgh_dehkordi@yahoo.com</email>
        <affiliation>Bushehr University of Medical Science</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Ghani Dehkordi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bushehr University of medical sciences</address>
        <city>Bushehr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 913 282 5389</telephone>
        <email>fgh_dehkordi@yahoo.com</email>
        <affiliation>Bushehr University of medical sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: women and men below the age of 70 who had been diagnosed with myocardial infarction for the first time; were able to read and write; were not suffering anxiety and psychosis related diseases.&#13;
Exclusion criteria: women and men with the age of more than 70 who had been diagnosed with myocardial infarction for more than once time; were unable to read and write;  participants who have suffering  from anxiety and psychosis related diseases.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I21</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>myocardial infarction specified as acute or with a stated duration of 4 weeks (28 days) or less from onset</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group: Patients were educated on symptoms, causes and side effects of myocardial infarction and change of life style such as smoking cessation, increase of physical activity, observance of food and drug regime, control of blood pressure, weight and management of anxiety. Education was performed in the form of individual education by researcher in patient’s room for 20 minutes and group education (2-5 patients) in hospital’s clinic for 20 minutes by the method of face-to-face education and educational-aid tools such as educational booklet given to patients. Also a fixed telephone number and a mobile phone number were provided to answer their questions.  Follow-up was made continuously for a period of four month following the first visit by phone.</i_keyword>
      <i_keyword>The control group: the control group did not receive any intervention and just Will receive only routine care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Heart Health Indexes. Timepoint: Before training and 4 months after completion of the training. Method of measurement: questionnair.</prim_outcome>
      <prim_outcome>Blood colestrol. Timepoint: Before training and 4 months after completion of the training. Method of measurement: labratory.</prim_outcome>
      <prim_outcome>Body max index. Timepoint: Before training and 4 months after completion of the training. Method of measurement: questionnair- bmi formol.</prim_outcome>
      <prim_outcome>Anexiety. Timepoint: Before training and 4 months after completion of the training. Method of measurement: questionnair.</prim_outcome>
      <prim_outcome>Blood presser (systol, diastol). Timepoint: Before training and 4 months after completion of the training. Method of measurement: Sphygmomanometer.</prim_outcome>
      <prim_outcome>Smoking. Timepoint: Before training and 4 months after completion of the training. Method of measurement: Quastionnair.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Heart Health Indexes. Timepoint: 4 mounth, before and after the training. Method of measurement: questionnair.</sec_outcome>
      <sec_outcome>Blood colestrol. Timepoint: 4 mounth, before and after the training. Method of measurement: labratoy.</sec_outcome>
      <sec_outcome>Body max index. Timepoint: 4 mounth, before and after the training. Method of measurement: body max index formol.</sec_outcome>
      <sec_outcome>Anxiety. Timepoint: 4 mounth. Method of measurement: beck anxiety questionnair.</sec_outcome>
      <sec_outcome>Blood presser (systol, diastol). Timepoint: 4 mounth, before and after the training. Method of measurement: Sphygmomanometer.</sec_outcome>
      <sec_outcome>Smoking. Timepoint: 4 mounth, before and after the training. Method of measurement: Quastionnair.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2008-02-09</approval_date>
        <contact_name>Iran university of medical science</contact_name>
        <contact_address>Tehran- Iran university of medical science Tehran  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
